Saïd Bichali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Saïd Bichali has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
Ali Houeijeh
Paediatric Cardiology, Univ. Lille, CHU Lille, Lille, France
5 shared publicationsAlexandre Delarue
3 shared publications- Alban-Elouen Baruteau
Nantes Université
2 shared publications - Ali Houeijeh
Institut CŒUR Poumon
2 shared publications Bénédicte Romefort
Cardio-Pediatrics Unit, Department of Pediatric Specialties, Nantes University Hospital, Nantes, France
2 shared publications- Elise Launay
Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064 , Nantes
2 shared publications
Latest Publications
- 23 December 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (1) , 35
Long-term impaired exercise capacity and oxygen consumption in Kawasaki disease patients
Kawasaki disease (KD) is a systemic inflammatory condition, likely triggered by a respiratory infection, inducing myocardial inflammation, and complicated with coronary aneurysms. The objectives are to measure the late cardiopulmonary exercise response and associate the severity of the acute episode with the long-term aerobic capacity. Data on the acute KD episode were collected retrospectively. Children and adolescents with past KD underwent standardized ergometer cardiopulmonary exercise testing. Regression analysis was used to associate coronary Z-scores and acute biomarkers, including maximum N-terminal pro-B-type natriuretic peptide (NT-proBNP), with the exercise parameters. Of 43 patients diagnosed with KD (mean age 4.97 ± 2.88 years, 42% females), 30 were age-and-sex matched after a mean of 6.78 ± 3.00 years (range 1.5–16 years) with 15 controls. Peak oxygen consumption (peakVO2) and ventilatory threshold were significantly decreased in KD patients (34.1 ± 11.1 versus 39.4 ± 7.2 mL·kg⁻1·min⁻1, p = 0.025, and 50.7 ± 13.7 versus 56.3 ± 11.8%, p = 0.036, respectively). Acute NT-proBNP and acute coronary Z-score were not associated with peakVO2 (odds ratio OR [95% confidence interval] 0.974 [0.734–1.293] and 1.023 [0.719–1.455], respectively). Instead, peakVO2 in KD patients with a persistent coronary aneurysm, defined by a coronary segment lumen greater than 1.5-fold that of the adjacent segment, was lower than controls (26.2 ± 6.4 versus 39.4 ± 7.2 mL·kg⁻1·min⁻1, p = 0.013). Conclusion: Children with KD had reduced aerobic capacity 7 years after the diagnosis. Maximum acute NT-proBNP and acute coronary Z-score were not associated with the late impaired exercise capacity, but persistent coronary aneurysms were. What is Known: • Acute coronary Z-score and blood NT-proBNP are markers of disease severity in Kawasaki disease. • Kawasaki disease is associated with late coronary ischaemic complications. What is New: • In Kawasaki disease patients, several years after the diagnosis, peak exercise mass-related oxygen consumption and ventilatory threshold are decreased, and body mass index is increased. • Persistent coronary aneurysms, but neither acute coronary Z-score nor acute maximum NT-proBNP, are associated with the late impaired exercise capacity.
- 23 December 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (1) , 35
Long-term impaired exercise capacity and oxygen consumption in Kawasaki disease patients
Kawasaki disease (KD) is a systemic inflammatory condition, likely triggered by a respiratory infection, inducing myocardial inflammation, and complicated with coronary aneurysms. The objectives are to measure the late cardiopulmonary exercise response and associate the severity of the acute episode with the long-term aerobic capacity. Data on the acute KD episode were collected retrospectively. Children and adolescents with past KD underwent standardized ergometer cardiopulmonary exercise testing. Regression analysis was used to associate coronary Z-scores and acute biomarkers, including maximum N-terminal pro-B-type natriuretic peptide (NT-proBNP), with the exercise parameters. Of 43 patients diagnosed with KD (mean age 4.97 ± 2.88 years, 42% females), 30 were age-and-sex matched after a mean of 6.78 ± 3.00 years (range 1.5–16 years) with 15 controls. Peak oxygen consumption (peakVO2) and ventilatory threshold were significantly decreased in KD patients (34.1 ± 11.1 versus 39.4 ± 7.2 mL·kg⁻1·min⁻1, p = 0.025, and 50.7 ± 13.7 versus 56.3 ± 11.8%, p = 0.036, respectively). Acute NT-proBNP and acute coronary Z-score were not associated with peakVO2 (odds ratio OR [95% confidence interval] 0.974 [0.734–1.293] and 1.023 [0.719–1.455], respectively). Instead, peakVO2 in KD patients with a persistent coronary aneurysm, defined by a coronary segment lumen greater than 1.5-fold that of the adjacent segment, was lower than controls (26.2 ± 6.4 versus 39.4 ± 7.2 mL·kg⁻1·min⁻1, p = 0.013). Conclusion: Children with KD had reduced aerobic capacity 7 years after the diagnosis. Maximum acute NT-proBNP and acute coronary Z-score were not associated with the late impaired exercise capacity, but persistent coronary aneurysms were. What is Known: • Acute coronary Z-score and blood NT-proBNP are markers of disease severity in Kawasaki disease. • Kawasaki disease is associated with late coronary ischaemic complications. What is New: • In Kawasaki disease patients, several years after the diagnosis, peak exercise mass-related oxygen consumption and ventilatory threshold are decreased, and body mass index is increased. • Persistent coronary aneurysms, but neither acute coronary Z-score nor acute maximum NT-proBNP, are associated with the late impaired exercise capacity.
- 12 March 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (2) , 696-708
Cardiogenic Shock Risk Score at Diagnosis of Multisystem Inflammatory Syndrome in Children: A Multicenter Study
Severe cardiovascular involvement is associated with mortality in multisystem inflammatory syndrome in children (MIS-C). This study aimed to test a previously published cardiogenic shock risk score at diagnosis of MIS-C and build a new screening tool in a larger pediatric cohort. The first score published in a single-center cohort (age > 8 years, time to diagnosis ≥ 6 days, and NT-proBNP at diagnosis ≥ 11.103 ng/L) was tested in a multicenter cohort of pediatric patients diagnosed with MIS-C from 2020 to 2023. In the multicenter cohort, the factors associated with the occurrence of cardiogenic shock were determined and a new score was built using a multivariate regression model. In 127 children with MIS-C, (median age [interquartile range] 8.6 [5.2; 11.5] years, 67 (53%) patients with cardiogenic shock), age > 8 years, time to treatment ≥ 6 days, dyspnea, altered mental status, general deterioration, gastrointestinal symptoms, ≤ 1 Kawasaki sign, absence of rhinopharyngitis signs, NT-proBNP ≥ 11.103 ng/L, high C-Reactive Protein (CRP), and high leucocytes at diagnosis of MIS-C were associated with a high risk of cardiogenic shock. The new score was 0.128*Age(year) + 1.195*(1 if dyspnea, 0 otherwise) + 0.007*CRP(mg/L) − 2.6732. The sensitivity was 0.88 and negative likelihood ratio 0.23 (cutoff − 0.4761). The score correlated with the minimal left ventricular ejection fraction (ρ = 0.51, p < 0.001). In a multicenter cohort, each item of the previous score was associated with the occurrence of cardiogenic shock. The new score, combining age, dyspnea, and CRP at diagnosis of MIS-C, had a high sensitivity.
- 12 March 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (2) , 696-708
Cardiogenic Shock Risk Score at Diagnosis of Multisystem Inflammatory Syndrome in Children: A Multicenter Study
Severe cardiovascular involvement is associated with mortality in multisystem inflammatory syndrome in children (MIS-C). This study aimed to test a previously published cardiogenic shock risk score at diagnosis of MIS-C and build a new screening tool in a larger pediatric cohort. The first score published in a single-center cohort (age > 8 years, time to diagnosis ≥ 6 days, and NT-proBNP at diagnosis ≥ 11.103 ng/L) was tested in a multicenter cohort of pediatric patients diagnosed with MIS-C from 2020 to 2023. In the multicenter cohort, the factors associated with the occurrence of cardiogenic shock were determined and a new score was built using a multivariate regression model. In 127 children with MIS-C, (median age [interquartile range] 8.6 [5.2; 11.5] years, 67 (53%) patients with cardiogenic shock), age > 8 years, time to treatment ≥ 6 days, dyspnea, altered mental status, general deterioration, gastrointestinal symptoms, ≤ 1 Kawasaki sign, absence of rhinopharyngitis signs, NT-proBNP ≥ 11.103 ng/L, high C-Reactive Protein (CRP), and high leucocytes at diagnosis of MIS-C were associated with a high risk of cardiogenic shock. The new score was 0.128*Age(year) + 1.195*(1 if dyspnea, 0 otherwise) + 0.007*CRP(mg/L) − 2.6732. The sensitivity was 0.88 and negative likelihood ratio 0.23 (cutoff − 0.4761). The score correlated with the minimal left ventricular ejection fraction (ρ = 0.51, p < 0.001). In a multicenter cohort, each item of the previous score was associated with the occurrence of cardiogenic shock. The new score, combining age, dyspnea, and CRP at diagnosis of MIS-C, had a high sensitivity.
- 17 December 2024
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (25) , 2031-2045
Essential Role of the RIα Subunit of cAMP-Dependent Protein Kinase in Regulating Cardiac Contractility and Heart Failure Development
BACKGROUND: The heart expresses 2 main subtypes of cAMP-dependent protein kinase (PKA; type I and II) that differ in their regulatory subunits, RIα and RIIα. Embryonic lethality of RIα knockout mice limits the current understanding of type I PKA function in the myocardium. The objective of this study was to test the role of RIα in adult heart contractility and pathological remodeling. METHODS: We measured PKA subunit expression in human heart and developed a conditional mouse model with cardiomyocyte-specific knockout of RIα (RIα-icKO). Myocardial structure and function were evaluated by echocardiography, histology, and ECG and in Langendorff-perfused hearts. PKA activity and cAMP levels were determined by immunoassay, and phosphorylation of PKA targets was assessed by Western blot. L-type Ca 2+ current ( I Ca,L ), sarcomere shortening, Ca 2+ transients, Ca 2+ sparks and waves, and subcellular cAMP were recorded in isolated ventricular myocytes (VMs). RESULTS: RIα protein was decreased by 50% in failing human heart with ischemic cardiomyopathy and by 75% in the ventricles and in VMs from RIα-icKO mice but not in atria or sinoatrial node. Basal PKA activity was increased ≈3-fold in RIα-icKO VMs. In young RIα-icKO mice, left ventricular ejection fraction was increased and the negative inotropic effect of propranolol was prevented, whereas heart rate and the negative chronotropic effect of propranolol were not modified. Phosphorylation of phospholamban, ryanodine receptor, troponin I, and cardiac myosin-binding protein C at PKA sites was increased in propranolol-treated RIα-icKO mice. Hearts from RIα-icKO mice were hypercontractile, associated with increased I Ca,L, and [Ca 2+ ] i transients and sarcomere shortening in VMs. These effects were suppressed by the PKA inhibitor, H89. Global cAMP content was decreased in RIα-icKO hearts, whereas local cAMP at the phospholamban/sarcoplasmic reticulum Ca 2+ ATPase complex was unchanged in RIα-icKO VMs. RIα-icKO VMs had an increased frequency of Ca 2+ sparks and proarrhythmic Ca 2+ waves, and RIα-icKO mice had an increased susceptibility to ventricular tachycardia. On aging, RIα-icKO mice showed progressive contractile dysfunction, cardiac hypertrophy, and fibrosis, culminating in congestive heart failure with reduced ejection fraction that caused 50% mortality at 1 year. CONCLUSIONS: These results identify RIα as a key negative regulator of cardiac contractile function, arrhythmia, and pathological remodeling.
- 17 December 2024
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (25) , 2031-2045
Essential Role of the RIα Subunit of cAMP-Dependent Protein Kinase in Regulating Cardiac Contractility and Heart Failure Development
BACKGROUND: The heart expresses 2 main subtypes of cAMP-dependent protein kinase (PKA; type I and II) that differ in their regulatory subunits, RIα and RIIα. Embryonic lethality of RIα knockout mice limits the current understanding of type I PKA function in the myocardium. The objective of this study was to test the role of RIα in adult heart contractility and pathological remodeling. METHODS: We measured PKA subunit expression in human heart and developed a conditional mouse model with cardiomyocyte-specific knockout of RIα (RIα-icKO). Myocardial structure and function were evaluated by echocardiography, histology, and ECG and in Langendorff-perfused hearts. PKA activity and cAMP levels were determined by immunoassay, and phosphorylation of PKA targets was assessed by Western blot. L-type Ca 2+ current ( I Ca,L ), sarcomere shortening, Ca 2+ transients, Ca 2+ sparks and waves, and subcellular cAMP were recorded in isolated ventricular myocytes (VMs). RESULTS: RIα protein was decreased by 50% in failing human heart with ischemic cardiomyopathy and by 75% in the ventricles and in VMs from RIα-icKO mice but not in atria or sinoatrial node. Basal PKA activity was increased ≈3-fold in RIα-icKO VMs. In young RIα-icKO mice, left ventricular ejection fraction was increased and the negative inotropic effect of propranolol was prevented, whereas heart rate and the negative chronotropic effect of propranolol were not modified. Phosphorylation of phospholamban, ryanodine receptor, troponin I, and cardiac myosin-binding protein C at PKA sites was increased in propranolol-treated RIα-icKO mice. Hearts from RIα-icKO mice were hypercontractile, associated with increased I Ca,L, and [Ca 2+ ] i transients and sarcomere shortening in VMs. These effects were suppressed by the PKA inhibitor, H89. Global cAMP content was decreased in RIα-icKO hearts, whereas local cAMP at the phospholamban/sarcoplasmic reticulum Ca 2+ ATPase complex was unchanged in RIα-icKO VMs. RIα-icKO VMs had an increased frequency of Ca 2+ sparks and proarrhythmic Ca 2+ waves, and RIα-icKO mice had an increased susceptibility to ventricular tachycardia. On aging, RIα-icKO mice showed progressive contractile dysfunction, cardiac hypertrophy, and fibrosis, culminating in congestive heart failure with reduced ejection fraction that caused 50% mortality at 1 year. CONCLUSIONS: These results identify RIα as a key negative regulator of cardiac contractile function, arrhythmia, and pathological remodeling.
- Open Access
- 30 October 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (11) , 2480-2483
Late complete atrioventricular block after transcatheter perimembranous ventricular septal defect closure with the KONAR-MF™ VSD occluder: a case report and systematic review
The soft nitinol KONAR-MF™ ventricular septal defect (VSD) Multifunctional Occluder (MFO) device is increasingly used for transcatheter perimembranous ventricular septal defect closure. We report for the first time a case of delayed complete atrioventricular block with pacemaker implantation 20 months post-procedure. Through a systematic review, the overall rate of persistent complete atrioventricular block was 0.6% with this device, but follow-up duration was limited.
- 30 October 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (11) , 2480-2483
Open AccessLate complete atrioventricular block after transcatheter perimembranous ventricular septal defect closure with the KONAR-MF™ VSD occluder: a case report and systematic review
The soft nitinol KONAR-MF™ ventricular septal defect (VSD) Multifunctional Occluder (MFO) device is increasingly used for transcatheter perimembranous ventricular septal defect closure. We report for the first time a case of delayed complete atrioventricular block with pacemaker implantation 20 months post-procedure. Through a systematic review, the overall rate of persistent complete atrioventricular block was 0.6% with this device, but follow-up duration was limited.
- 2 October 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (10) , 2240-2243
Atrial flow regulator in transposition of the great arteries, ventricular septal defect, and pulmonary stenosis: a case report
A 5-month-old girl with transposition of the great arteries, ventricular septal defect, and pulmonary stenosis underwent the implantation of a 6-mm M Atrial Flow Regulator (Occlutech) over an 8-French delivery sheath for significant cyanosis and progressive restriction of the atrial septal defect, without adverse event for 6 months. The Atrial Flow Regulator device could improve blood mixing as a bridge to surgery.
- 2 October 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (10) , 2240-2243
Atrial flow regulator in transposition of the great arteries, ventricular septal defect, and pulmonary stenosis: a case report
A 5-month-old girl with transposition of the great arteries, ventricular septal defect, and pulmonary stenosis underwent the implantation of a 6-mm M Atrial Flow Regulator (Occlutech) over an 8-French delivery sheath for significant cyanosis and progressive restriction of the atrial septal defect, without adverse event for 6 months. The Atrial Flow Regulator device could improve blood mixing as a bridge to surgery.
- Open Access
- 26 September 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (10) , 2231-2232
Aberrant right subclavian artery stenting and embolisation for button battery-induced recurrent arterio-oesophageal fistula
A young child, who had a previously unsuspected aberrant right subclavian retro-oesophageal artery, swallowed a button battery complicated with recurrent life-threatening bleeding, and survived after repeated percutaneous treatment as a bridge to surgery.
- 26 September 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (10) , 2231-2232
Open AccessAberrant right subclavian artery stenting and embolisation for button battery-induced recurrent arterio-oesophageal fistula
A young child, who had a previously unsuspected aberrant right subclavian retro-oesophageal artery, swallowed a button battery complicated with recurrent life-threatening bleeding, and survived after repeated percutaneous treatment as a bridge to surgery.
- 11 January 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (4) , 1667-1674
NT-proBNP course during MIS-C post-COVID-19: an observational study
Multisystem inflammatory syndrome in children (MIS-C or PIMS-TS) is a severe disease. N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used for positive and differential diagnosis, diagnosis of complications and severity, and cardiogenic shock prediction. However, contrasting cut-offs have been suggested. The aims of the present study were to compare NT-proBNP values depending on the time of measurement and to describe the NT-proBNP course during the MIS-C episode. The data from a single-centre cohort observational study on the impact of time to diagnosis, defined as the time from first symptom to diagnosis of MIS-C, were used for the purpose of this study, with an extended period of inclusion from May 2020 to April 2023. The timing and level of all NT-proBNP samples available for each patient were retrospectively collected. Thirty-seven children (18 (49%) females, median age 8.8 years, 14 (38%) with shock) were included. Until diagnosis, NT-proBNP increased with time and was significantly higher at 6 days from first symptoms than at 3 days (median (interquartile range) 32,933 (7773–61,592) versus 1994 (1291–4190) pg/mL, respectively, p = 0.031). From diagnosis, NT-proBNP decreased by at least 50% after 3.0 (2.1–5.3) days (n = 12) when NT-proBNP at diagnosis was low ≤ 11,000 pg/mL versus 1.8 (0.7–3.4) days (n = 16) when NT-proBNP at diagnosis was high (p = 0.040), and after 3.6 (2.4–5.9) days (n = 7) when fever persisted after 48 h versus 1.8 (0.8–3.0) days (n = 21) when fever resolved before 48 h (p = 0.004). Conclusions: During the MIS-C episode, NT-proBNP increased over time until diagnosis and treatment. It dropped faster thereafter in children with high NT-proBNP at diagnosis > 11,000 pg/mL and slower in case of persistent fever. What is Known: • NT-proBNP is useful in MIS-C for positive and differential diagnosis, diagnosis of complications and severity, and cardiogenic shock prediction. • Contrasting cut-offs for differential diagnosis and severity assessment have been suggested. What is New: • Before diagnosis, NT-proBNP increases with time and is significantly higher at 6 days from first symptoms than at 3 days suggesting different cut-offs depending on the timing of measurement. • From diagnosis and treatment initiation, the 50% NT-proBNP drop occurs earlier in children with high NT-proBNP at diagnosis > 11,000 pg/mL and later in children with persistent fever.
- 11 January 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (4) , 1667-1674
NT-proBNP course during MIS-C post-COVID-19: an observational study
Multisystem inflammatory syndrome in children (MIS-C or PIMS-TS) is a severe disease. N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used for positive and differential diagnosis, diagnosis of complications and severity, and cardiogenic shock prediction. However, contrasting cut-offs have been suggested. The aims of the present study were to compare NT-proBNP values depending on the time of measurement and to describe the NT-proBNP course during the MIS-C episode. The data from a single-centre cohort observational study on the impact of time to diagnosis, defined as the time from first symptom to diagnosis of MIS-C, were used for the purpose of this study, with an extended period of inclusion from May 2020 to April 2023. The timing and level of all NT-proBNP samples available for each patient were retrospectively collected. Thirty-seven children (18 (49%) females, median age 8.8 years, 14 (38%) with shock) were included. Until diagnosis, NT-proBNP increased with time and was significantly higher at 6 days from first symptoms than at 3 days (median (interquartile range) 32,933 (7773–61,592) versus 1994 (1291–4190) pg/mL, respectively, p = 0.031). From diagnosis, NT-proBNP decreased by at least 50% after 3.0 (2.1–5.3) days (n = 12) when NT-proBNP at diagnosis was low ≤ 11,000 pg/mL versus 1.8 (0.7–3.4) days (n = 16) when NT-proBNP at diagnosis was high (p = 0.040), and after 3.6 (2.4–5.9) days (n = 7) when fever persisted after 48 h versus 1.8 (0.8–3.0) days (n = 21) when fever resolved before 48 h (p = 0.004). Conclusions: During the MIS-C episode, NT-proBNP increased over time until diagnosis and treatment. It dropped faster thereafter in children with high NT-proBNP at diagnosis > 11,000 pg/mL and slower in case of persistent fever. What is Known: • NT-proBNP is useful in MIS-C for positive and differential diagnosis, diagnosis of complications and severity, and cardiogenic shock prediction. • Contrasting cut-offs for differential diagnosis and severity assessment have been suggested. What is New: • Before diagnosis, NT-proBNP increases with time and is significantly higher at 6 days from first symptoms than at 3 days suggesting different cut-offs depending on the timing of measurement. • From diagnosis and treatment initiation, the 50% NT-proBNP drop occurs earlier in children with high NT-proBNP at diagnosis > 11,000 pg/mL and later in children with persistent fever.
- 25 October 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 33 (12) , 2685-2689
Anomalous hepatic drainage and platypnea-orthodeoxia in cyanotic children
The aetiology of cyanosis could be unclear in children, even for specialised paediatricians. Two cases were reported: first, a 6-year-old child with features of left isomerism and Fallot was fortuitously diagnosed with anomalous hepatic venous drainage before complete repair. Second, a newborn with an antenatal diagnosis of ductus venosus agenesis had an isolated intermittent right-to-left atrial shunt when upright, with favourable outcome, in contrast to the association with significant heart malformations including inferior caval vein interruption. Multimodality imaging and 3D printing helped to rule out extracardiac causes of persistent cyanosis and plan surgical repair.
- 25 October 2023
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 33 (12) , 2685-2689
Anomalous hepatic drainage and platypnea-orthodeoxia in cyanotic children
The aetiology of cyanosis could be unclear in children, even for specialised paediatricians. Two cases were reported: first, a 6-year-old child with features of left isomerism and Fallot was fortuitously diagnosed with anomalous hepatic venous drainage before complete repair. Second, a newborn with an antenatal diagnosis of ductus venosus agenesis had an isolated intermittent right-to-left atrial shunt when upright, with favourable outcome, in contrast to the association with significant heart malformations including inferior caval vein interruption. Multimodality imaging and 3D printing helped to rule out extracardiac causes of persistent cyanosis and plan surgical repair.
- Open Access
- 6 January 2023
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 19 (6) , 595-604
Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection
Background In multisystem inflammatory syndrome in children (MIS-C), diagnostic delay could be associated with severity. This study aims to measure the time to diagnosis in MIS-C, assess its impact on the occurrence of cardiogenic shock, and specify its determinants. Methods A single-center prospective cohort observational study was conducted between May 2020 and July 2022 at a tertiary care hospital. Children meeting the World Health Organization MIS-C criteria were included. A long time to diagnosis was defined as six days or more. Data on time to diagnosis were collected by two independent physicians. The primary outcome was the occurrence of cardiogenic shock. Logistic regression and receiver operating characteristic curve analysis were used for outcomes, and a Cox proportional hazards model was used for determinants. Results Totally 60 children were assessed for inclusion, and 31 were finally analyzed [52% males, median age 8.8 (5.7–10.7) years]. The median time to diagnosis was 5.3 (4.2–6.2) days. In univariable analysis, age above the median, time to diagnosis, high C-reactive protein, and high N-terminal pro-B-type natriuretic peptide (NT-proBNP) were associated with cardiogenic shock [odds ratio (OR) 6.13 (1.02–36.9), 2.79 (1.15–6.74), 2.08 (1.05–4.12), and 1.70 (1.04–2.78), respectively]. In multivariable analysis, time to diagnosis ≥ 6 days was associated with cardiogenic shock [adjusted OR (aOR) 21.2 (1.98–227)]. Time to diagnosis ≥ 6 days had a sensitivity of 89% and a specificity of 77% in predicting cardiogenic shock; the addition of age > 8 years and NT-proBNP at diagnosis ≥ 11,254 ng/L increased the specificity to 91%. Independent determinants of short time to diagnosis were age < 8.8 years [aHR 0.34 (0.13–0.88)], short distance to tertiary care hospital [aHR 0.27 (0.08–0.92)], and the late period of the COVID-19 pandemic [aHR 2.48 (1.05–5.85)]. Conclusions Time to diagnosis ≥ 6 days was independently associated with cardiogenic shock in MIS-C. Early diagnosis and treatment are crucial to avoid the use of inotropes and limit morbidity, especially in older children.
- 6 January 2023
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 19 (6) , 595-604
Open AccessImpact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection
Background In multisystem inflammatory syndrome in children (MIS-C), diagnostic delay could be associated with severity. This study aims to measure the time to diagnosis in MIS-C, assess its impact on the occurrence of cardiogenic shock, and specify its determinants. Methods A single-center prospective cohort observational study was conducted between May 2020 and July 2022 at a tertiary care hospital. Children meeting the World Health Organization MIS-C criteria were included. A long time to diagnosis was defined as six days or more. Data on time to diagnosis were collected by two independent physicians. The primary outcome was the occurrence of cardiogenic shock. Logistic regression and receiver operating characteristic curve analysis were used for outcomes, and a Cox proportional hazards model was used for determinants. Results Totally 60 children were assessed for inclusion, and 31 were finally analyzed [52% males, median age 8.8 (5.7–10.7) years]. The median time to diagnosis was 5.3 (4.2–6.2) days. In univariable analysis, age above the median, time to diagnosis, high C-reactive protein, and high N-terminal pro-B-type natriuretic peptide (NT-proBNP) were associated with cardiogenic shock [odds ratio (OR) 6.13 (1.02–36.9), 2.79 (1.15–6.74), 2.08 (1.05–4.12), and 1.70 (1.04–2.78), respectively]. In multivariable analysis, time to diagnosis ≥ 6 days was associated with cardiogenic shock [adjusted OR (aOR) 21.2 (1.98–227)]. Time to diagnosis ≥ 6 days had a sensitivity of 89% and a specificity of 77% in predicting cardiogenic shock; the addition of age > 8 years and NT-proBNP at diagnosis ≥ 11,254 ng/L increased the specificity to 91%. Independent determinants of short time to diagnosis were age < 8.8 years [aHR 0.34 (0.13–0.88)], short distance to tertiary care hospital [aHR 0.27 (0.08–0.92)], and the late period of the COVID-19 pandemic [aHR 2.48 (1.05–5.85)]. Conclusions Time to diagnosis ≥ 6 days was independently associated with cardiogenic shock in MIS-C. Early diagnosis and treatment are crucial to avoid the use of inotropes and limit morbidity, especially in older children.
- 12 October 2022
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 33 (7) , 1186-1188
Sclerotherapy of oesophageal varices may induce chronic constrictive pericarditis in children
Constrictive pericarditis is rare in children and can be difficult to diagnose. It has been described in adults after sclerotherapy of oesophageal varices but not in children. We report two cases of chronic constrictive pericarditis after sclerotherapy of oesophageal varices in children with portal cavernoma. Constrictive pericarditis should be considered as a cause of refractory ascites.
- 12 October 2022
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 33 (7) , 1186-1188
Sclerotherapy of oesophageal varices may induce chronic constrictive pericarditis in children
Constrictive pericarditis is rare in children and can be difficult to diagnose. It has been described in adults after sclerotherapy of oesophageal varices but not in children. We report two cases of chronic constrictive pericarditis after sclerotherapy of oesophageal varices in children with portal cavernoma. Constrictive pericarditis should be considered as a cause of refractory ascites.